|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|---|---|---|
| ASSETS: | |||||||
| Current assets: | |||||||
| Cash | |||||||
| Deferred offering costs associated with public offering | |||||||
| Prepaid expenses | |||||||
| Total current assets | |||||||
| Investments held in Trust Account | |||||||
| Total assets | |||||||
| Current liabilities: | |||||||
| Accrued expenses | |||||||
| Notes payable - related party | |||||||
| Total current liabilities | |||||||
| Liabilities, Noncurrent | |||||||
| Public warrants derivative liability | |||||||
| Advisory fee | |||||||
| Deferred underwriting compensation | |||||||
| Total liabilities | |||||||
| Class A ordinary shares subject to possible redemption, 35,880,000 shares (at redemption value of $10.51 and $10.25 per share at September 30, 2026 and December 31, 2025, respectively) | |||||||
| Shareholders' deficit: | |||||||
| Common stock value | |||||||
| Class A Ordinary Shares | |||||||
| Class B Ordinary Shares | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Total shareholders' deficit | |||||||
| Total liabilities and shareholders' deficit |
Loading...